cas 2382942-35-8|| where to buy N-{9-[(2R,3R,4R,5R)-5-{[bis(4-methoxyphenyl)(phenyl)methoxy]methyl}-4-({[bis(propan-2-yl)amino](2-cyanoethoxy)phosphanyl}oxy)-3-(hexadecyloxy)oxolan-2-yl]-9H-purin-6-yl}benzamide

Nom du produit:N-{9-[(2R,3R,4R,5R)-5-{[bis(4-methoxyphenyl)(phenyl)methoxy]methyl}-4-({[bis(propan-2-yl)amino](2-cyanoethoxy)phosphanyl}oxy)-3-(hexadecyloxy)oxolan-2-yl]-9H-purin-6-yl}benzamide

IUPAC Name:N-{9-[(2R,3R,4R,5R)-5-{[bis(4-methoxyphenyl)(phenyl)methoxy]methyl}-4-({[bis(propan-2-yl)amino](2-cyanoethoxy)phosphanyl}oxy)-3-(hexadecyloxy)oxolan-2-yl]-9H-purin-6-yl}benzamide

: CAS：2382942-35-8; Formule moléculaire：C63H84N7O8P; Pureté：95%+

: Numéro de catalogue：CM1079375; Poids moléculaire：1098.38

Unité d'emballage	Stock disponible	Prix($)	Quantité

Demande: sales@chemenu.com

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2382942-35-8 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

Détails du produit

: N° CAS:2382942-35-8; Formule moléculaire:C63H84N7O8P; Point de fusion:-; Code SMILES:CCCCCCCCCCCCCCCCO[C@@H]1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)NC(=O)C4=CC=CC=C4)COC(C5=CC=CC=C5)(C6=CC=C(C=C6)OC)C7=CC=C(C=C7)OC)OP(N(C(C)C)C(C)C)OCCC#N; Densité:

: Numéro de catalogue:CM1079375; Poids moléculaire:1098.38; Point d'ébullition:; N° Mdl:; Stockage:

Category Infos

: Nucleosides and Nucleotides; Nucleosides consist of a nucleotide and a five-carbon sugar, and a nucleotide consists of a nucleotide, a five-carbon sugar, and one or more phosphate groups.; nucleoside manufacturer; As a professional nucleoside manufacturer, we can guarantee product quality and delivery time.our company has been committed to supply personalized product solutions to customers,pls consult us.